The Problem: Ransomware With a presence in 120 countries worldwide and revenue in excess of $1 billion, this leading pharmaceutical company operates manufacturing facilities across the US, Europe, and Asia. Dedicated to ongoing innovation, the company has built an extensive portfolio of innovative medicines across multiple therapeutic areas. Just as they rolled out a major distribution and marketing expansion in Europe, the firm was breached via malware that entered their network via a VPN connection originating in Asia. The malware then spread to manufacturing facilities in both the US and UK. Luckily, the malware failed to encrypt the hard drives it infected, and the plants survived unscathed. Had the malware successfully executed its payload, the fi

Join for free to read